PMID- 38469303 OWN - NLM STAT- MEDLINE DCOM- 20240313 LR - 20240412 IS - 1664-3224 (Electronic) IS - 1664-3224 (Linking) VI - 15 DP - 2024 TI - Gene-edited pigs: a translational model for human food allergy against alpha-Gal and anaphylaxis. PG - 1358178 LID - 10.3389/fimmu.2024.1358178 [doi] LID - 1358178 AB - The prevalence of food allergy is rising and is estimated to approach 10%. Red meat allergy is the first known food allergy elicited by immunoglobulin E (IgE) antibodies recognizing a carbohydrate. Due to the loss of function of the alpha-1,3-galactosyltransferase (GGTA1) gene in humans, the disaccharide galactose-alpha-1,3-galactose (alpha-Gal) cannot be synthesized and therefore became immunogenic. IgE sensitization is elicited through the skin by repetitive tick bites transmitting alpha-Gal. The underlying mechanisms regarding innate and adaptive immune cell activation, including the B-cell isotype switch to IgE, are poorly understood, requiring further research and physiologically relevant animal models. Here, we describe a new animal model of red meat allergy using percutaneous alpha-Gal sensitization of gene-edited GGTA1-deficient pigs. Total and alpha-Gal-specific IgG, IgG1, IgG2, IgG4, and IgE levels were tracked. Further key factors associated with allergic skin inflammation, type 2 immunity, and allergy development were measured in PBMCs and skin samples. Significant increases in alpha-Gal-specific IgG1 and IgE levels indicated successful sensitization to the allergen alpha-Gal. Intracutaneous sensitizations with alpha-Gal recruited lymphocytes to the skin, including elevated numbers of T helper 2 (Th2) cells. Finally, alpha-Gal-sensitized pigs not only recognized alpha-Gal as non-self-antigen following alpha-Gal exposure through the skin but also developed anaphylaxis upon antigen challenge. Based on the similarities between the porcine and human skin, this new large animal model for alpha-Gal allergy should help to unveil the consecutive steps of cutaneous sensitization and aid the development of prophylactic and treatment interventions. CI - Copyright (c) 2024 Wang, Hils, Fischer, Wolbing, Biedermann, Schnieke and Fischer. FAU - Wang, Ying AU - Wang Y AD - Chair of Livestock Biotechnology, School of Life Sciences Weihenstephan, Technical University of Munich, Freising, Germany. FAU - Hils, Miriam AU - Hils M AD - Department of Dermatology and Allergy Biederstein, School of Medicine, Technical University of Munich, Munich, Germany. FAU - Fischer, Andrea AU - Fischer A AD - Chair of Livestock Biotechnology, School of Life Sciences Weihenstephan, Technical University of Munich, Freising, Germany. FAU - Wolbing, Florian AU - Wolbing F AD - Department of Dermatology and Allergy Biederstein, School of Medicine, Technical University of Munich, Munich, Germany. FAU - Biedermann, Tilo AU - Biedermann T AD - Department of Dermatology and Allergy Biederstein, School of Medicine, Technical University of Munich, Munich, Germany. FAU - Schnieke, Angelika AU - Schnieke A AD - Chair of Livestock Biotechnology, School of Life Sciences Weihenstephan, Technical University of Munich, Freising, Germany. FAU - Fischer, Konrad AU - Fischer K AD - Chair of Livestock Biotechnology, School of Life Sciences Weihenstephan, Technical University of Munich, Freising, Germany. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20240226 PL - Switzerland TA - Front Immunol JT - Frontiers in immunology JID - 101560960 RN - X2RN3Q8DNE (Galactose) RN - 37341-29-0 (Immunoglobulin E) RN - 0 (Immunoglobulin G) RN - red meat allergy SB - IM MH - Humans MH - Animals MH - Swine MH - *Anaphylaxis MH - Galactose MH - Gene Editing MH - *Food Hypersensitivity MH - Immunoglobulin E MH - Immunoglobulin G PMC - PMC10925645 OTO - NOTNLM OT - anaphylaxis to alpha-Gal OT - intracutaneous sensitization OT - red meat allergy OT - translational pig model OT - alpha-Gal allergy COIS- The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2024/03/12 06:43 MHDA- 2024/03/13 06:46 PMCR- 2024/01/01 CRDT- 2024/03/12 03:54 PHST- 2023/12/19 00:00 [received] PHST- 2024/02/06 00:00 [accepted] PHST- 2024/03/13 06:46 [medline] PHST- 2024/03/12 06:43 [pubmed] PHST- 2024/03/12 03:54 [entrez] PHST- 2024/01/01 00:00 [pmc-release] AID - 10.3389/fimmu.2024.1358178 [doi] PST - epublish SO - Front Immunol. 2024 Feb 26;15:1358178. doi: 10.3389/fimmu.2024.1358178. eCollection 2024.